February 23, 2015
Posted February 23, 2015
The FTC has challenged marketers of “melanoma detection” apps, MelApp and Mole Detective, for deceptively claiming their mobile apps could detect symptoms of melanoma, even in its early stages, without scientific evidence to back up its claims. FTC
Tagged in: Healthcare Fraud,